![](/img/cover-not-exists.png)
A Relative Cost of Control Analysis of Once-Weekly Semaglutide Versus Exenatide Extended-Release and Dulaglutide for Bringing Patients to HbA1c and Weight Loss Treatment Targets in the USA
Johansen, Pierre, Hunt, Barnaby, Iyer, Neeraj N., Dang-Tan, Tam, Pollock, Richard F.Journal:
Advances in Therapy
DOI:
10.1007/s12325-019-00915-8
Date:
March, 2019
File:
PDF, 780 KB
2019